These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8100728)

  • 21. Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.
    Westfall TC; Naes L; Paul C
    J Pharmacol Exp Ther; 1983 Jan; 224(1):199-205. PubMed ID: 6848743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum.
    Neff NH; Wemlinger TA; Duchemin AM; Hadjiconstantinou M
    J Pharmacol Exp Ther; 2006 May; 317(2):480-7. PubMed ID: 16415089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis].
    Raevskiĭ KS; Shemanov AIu; Kudrin VS
    Farmakol Toksikol; 1982; 45(5):5-8. PubMed ID: 6128254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lead exposure on dopaminergic transmission in the rat brain.
    NourEddine D; Miloud S; Abdelkader A
    Toxicology; 2005 Feb; 207(3):363-8. PubMed ID: 15664264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
    Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
    Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
    Jenner P; Marsden CD
    Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
    [No Abstract]   [Full Text] [Related]  

  • 29. Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs.
    Hong JS; Yang HY; Fratta W; Costa E
    J Pharmacol Exp Ther; 1978 Apr; 205(1):141-7. PubMed ID: 24732
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of chronic neuroleptic treatment on tyrosine hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance.
    Gale K
    Adv Biochem Psychopharmacol; 1980; 24():23-9. PubMed ID: 6105777
    [No Abstract]   [Full Text] [Related]  

  • 31. [The pharmacological properties of karazedin].
    Barkov NK; Serpilina NM; Surkova LA; Sharkova LM; Rusakov DIu; Tiurina IV
    Eksp Klin Farmakol; 1994; 57(2):4-6. PubMed ID: 7911367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative evaluation of the effect of carbidine and levamisole on the E-rosette-forming activity of the lymphocytes in alcoholic intoxication].
    Proskuriakova TV; Gurtovenko VM; Gorshkova EP
    Farmakol Toksikol; 1989; 52(1):94-8. PubMed ID: 2565251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of carbidine on conditioned defense reflexes].
    Barkov NK; Ostrovskaia RU
    Biull Eksp Biol Med; 1975 Apr; 79(4):61-4. PubMed ID: 105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Brain dopamine depleted by d-tetrahydropalmatine].
    Xu SX; Jin GZ; Yu LP; Liu GX; Lu WW; Fang SD
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):207-12. PubMed ID: 2444064
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life.
    Velley L; Blanc G; Tassin JP; Thierry AM; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(1):97-102. PubMed ID: 240129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic involvement in the process of reinforcement from diethyl ether vapor in rats.
    Pogorelov VM; Kovalev GI
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1135-56. PubMed ID: 10621954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine and chronic antipsychotic drug treatment.
    Bowers MB
    Psychopharmacol Bull; 1979 Jan; 15(1):55-6. PubMed ID: 33409
    [No Abstract]   [Full Text] [Related]  

  • 38. [Indoles. 10. Synthesis, structure and D2-affinity of beta-carboline analogs of flutroline].
    Lehmann J; Knoch F; Jiang N
    Arch Pharm (Weinheim); 1993 Dec; 326(12):947-51. PubMed ID: 7907210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of neuroleptics on spontaneous and evoked noradrenaline release from brain nerve endings of rats].
    Arefolov VA; Panasiuk LV; Maisov NI; Malikova LA
    Farmakol Toksikol; 1979; 42(1):11-5. PubMed ID: 33828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptics from the 4a,9b-cis- and 4a,9b-trans-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole series. 2.
    Welch WM; Harbert CA; Weissman A; Koe BK
    J Med Chem; 1986 Oct; 29(10):2093-9. PubMed ID: 2876102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.